Sverrir Harðarson
Impact in
-
- Renal cell carcinoma treatment
Papers in
-
- Renal cell carcinoma treatment 9
- Oncology 5
- Viral-associated cancers and disorders 4
- Co-authors
- Tómas Guðbjartsson (10 shared papers)Guðmundur Einarsson (9 shared papers)Vigdís Pétursdóttir (8 shared papers)Ásgeir Thoroddsen (5 shared papers)Jónas Magnússon (4 shared papers)Eiríkur Jónsson (6 shared papers)Martin I. Sigurðsson (3 shared papers)Cyril Fisher (1 shared paper)
- Journals
- International Journal of Cancer (2 papers)Apmis (1 paper)European Urology (1 paper)Ophthalmology (1 paper)Journal of Cutaneous Pathology (1 paper)
- Partner nations
- IcelandUnited StatesSweden
In The Last Decade
Sverrir Harðarson
23 papers receiving 622 citations
Peers
Comparison fields: 5 of 66
- Pulmonary and Respiratory Medicine 349
- Nephrology 33
- Cancer Research 65
- Oncology 111
- Molecular Biology 195
Countries citing papers authored by Sverrir Harðarson
This map shows the geographic impact of Sverrir Harðarson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sverrir Harðarson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sverrir Harðarson more than expected).
Fields of papers citing papers by Sverrir Harðarson
This network shows the impact of papers produced by Sverrir Harðarson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sverrir Harðarson. The network helps show where Sverrir Harðarson may publish in the future.
Co-authors
The 25 scholars most cited alongside Sverrir Harðarson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 157 | |
| 2 | 2005 | 82 | |
| 3 | 2020 | 67 | |
| 4 | 2002 | 65 | |
| 5 | 2011 | 53 | |
| 6 | 2005 | 49 | |
| 7 | 1999 | 34 | |
| 8 | 1998 | 21 | |
| 9 | 2007 | 19 | |
| 10 | 1997 | 17 | |
| 11 | 2010 | 14 | |
| 12 | 2014 | 14 | |
| 13 | 2012 | 12 | |
| 14 | 1992 | 11 | |
| 15 | 1994 | 11 | |
| 16 | 2008 | 6 | |
| 17 | 2013 | 4 | |
| 18 | [Renal cell carcinoma diagnosed at autopsy in Iceland 1971-2005]. | 2008 | 4 |
| 19 | 2006 | 4 | |
| 20 | 2011 | 2 |
About Sverrir Harðarson
Sverrir Harðarson is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Pathology and Forensic Medicine, Physiology and Molecular Biology, having authored 23 papers that have together received 649 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (9 papers), Viral-associated cancers and disorders (4 papers), Lymphoma Diagnosis and Treatment (3 papers), Histiocytic Disorders and Treatments (3 papers), Renal Diseases and Glomerulopathies (2 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper), Urologic and reproductive health conditions (1 paper) and Genetic and Kidney Cyst Diseases (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (349 citations), Nephrology (33 citations), Cancer Research (65 citations), Oncology (111 citations) and Molecular Biology (195 citations). Sverrir Harðarson has collaborated with scholars based in Iceland, United States and Sweden. Frequent co-authors include Tómas Guðbjartsson, Guðmundur Einarsson, Vigdís Pétursdóttir, Ásgeir Thoroddsen, Jónas Magnússon, Eiríkur Jónsson, Martin I. Sigurðsson, Cyril Fisher, Mark E. Smith and Kristleifur Kristjánsson. Their work appears in journals such as International Journal of Cancer, Apmis, European Urology, Ophthalmology and Journal of Cutaneous Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.